ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Regulatory Genome Development Ltd

Regulatory Genome Development Ltd is an active company incorporated on 7 September 2020 with the registered office located in Cambridge, Cambridgeshire. Regulatory Genome Development Ltd was registered 5 years ago.
Status
Active
Active since incorporation
Company No
12862325
Private limited company
Age
5 years
Incorporated 7 September 2020
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 23 April 2025 (6 months ago)
Next confirmation dated 23 April 2026
Due by 7 May 2026 (6 months remaining)
Last change occurred 2 years 5 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (11 months remaining)
Address
Box 112 23 King Street
Cambridge
CB1 1AH
United Kingdom
Address changed on 27 Jun 2022 (3 years ago)
Previous address was 208 Mill Road Cambridge Cambridgeshire CB1 3NF
Telephone
01223 339700
Email
Unreported
People
Officers
4
Shareholders
24
Controllers (PSC)
1
Director • British • Lives in UK • Born in Nov 1957
Director • Lecturer • British • Lives in England • Born in Sep 1957
Director • Ceo • British • Lives in UK • Born in May 1970
Director • Managing Partner • American • Lives in United States • Born in Jul 1965
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Panaseer Limited
Richard Michael Seewald is a mutual person.
Active
International Alternative Finance C.I.C
Mr Robert Hugh Wardrop is a mutual person.
Active
Brands
RegGenome
RegGenome is a regulatory data technology company that converts regulatory information into machine-readable formats using AI.
Financials
Net Assets, Total Assets & Total Liabilities (2021–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£154K
Decreased by £2.13M (-93%)
Turnover
£161K
Decreased by £247.69K (-61%)
Employees
Unreported
Same as previous period
Total Assets
£468K
Decreased by £2.3M (-83%)
Total Liabilities
-£9.01M
Increased by £1.88M (+26%)
Net Assets
-£8.54M
Decreased by £4.18M (+96%)
Debt Ratio (%)
1924%
Increased by 1666.6% (+647%)
Latest Activity
Full Accounts Submitted
26 Days Ago on 29 Sep 2025
Confirmation Submitted
6 Months Ago on 28 Apr 2025
Mark Johnston Appointed
12 Months Ago on 28 Oct 2024
Full Accounts Submitted
1 Year Ago on 30 Sep 2024
Confirmation Submitted
1 Year 5 Months Ago on 7 May 2024
John Robert Stuart Dodsworth Resigned
1 Year 5 Months Ago on 2 May 2024
Mr Richard Michael Seewald Details Changed
1 Year 6 Months Ago on 23 Apr 2024
Full Accounts Submitted
1 Year 11 Months Ago on 1 Nov 2023
Confirmation Submitted
2 Years 5 Months Ago on 2 May 2023
Mr Richard Michael Seewald Details Changed
2 Years 6 Months Ago on 23 Apr 2023
Get Credit Report
Discover Regulatory Genome Development Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Total exemption full accounts made up to 31 December 2024
Submitted on 29 Sep 2025
Second filing of Confirmation Statement dated 23 April 2025
Submitted on 15 May 2025
Confirmation statement made on 23 April 2025 with no updates
Submitted on 28 Apr 2025
Appointment of Mark Johnston as a director on 28 October 2024
Submitted on 4 Nov 2024
Total exemption full accounts made up to 31 December 2023
Submitted on 30 Sep 2024
Termination of appointment of John Robert Stuart Dodsworth as a secretary on 2 May 2024
Submitted on 21 May 2024
Confirmation statement made on 23 April 2024 with no updates
Submitted on 7 May 2024
Director's details changed for Mr Richard Michael Seewald on 23 April 2024
Submitted on 7 May 2024
Total exemption full accounts made up to 31 December 2022
Submitted on 1 Nov 2023
Confirmation statement made on 23 April 2023 with updates
Submitted on 2 May 2023
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year